Stay updated on Risankizumab in PsA Patients: Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study page now displays a recruitment-closed notice and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) to guide users.
    Difference
    0.1%
    Check dated 2026-06-12T23:51:32.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The revision line at the bottom shows Revision: v3.5.5, replacing the previous v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-05T22:08:18.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The Ukraine location entry was updated to standardize the location as Kharkiv Oblast, Ukraine. The city line now reads Kharkiv, Kharkiv Oblast, Ukraine, 61039.
    Difference
    0.0%
    Check dated 2026-05-29T23:08:18.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page no longer displays the AbbVie sponsor attribution and the auxiliary sections 'Related Info' and 'Helpful Links Provided by', altering how users access sponsor details and related resources for this study.
    Difference
    0.0%
    Check dated 2026-05-22T16:16:40.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now displays a new revision tag, replacing the previous v3.5.3 with v3.5.4. This indicates a software release or UI/template update to the page rather than changes to the study details or content.
    Difference
    0.0%
    Check dated 2026-05-15T14:12:05.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Two trial-site entries were updated to use correctly spelled city names with diacritics (Malmö and Taoyuan City) instead of the previously listed forms. The update standardizes geographic identifiers on the study's site list while preserving the country and postal code information.
    Difference
    0.0%
    Check dated 2026-05-08T09:58:58.000Z thumbnail image

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.